CD4 and metabolic dysfunction-associated steatohepatitis: Through single-cell approaches, we identify significant changes in the heterogeneity of hepatic CD4+ T-cell subsets during MASH, characterized mainly by the expansion of Th1, Treg, and cytotoxic populations in both the liver and peripheral blood.